Brazilian Journal of Anesthesiology
https://app.periodikos.com.br/journal/rba/article/doi/10.1590/S0034-70942005000400007
Brazilian Journal of Anesthesiology
Scientific Article

Efeitos da dexmedetomidina sobre o sistema renal e sobre a concentração plasmática do hormônio antidiurético: estudo experimental em cães

Effects of dexmedetomidine on renal system and on vasopressin plasma levels: experimental study in dogs

Nivaldo Ribeiro Villela; Paulo do Nascimento Júnior; Lídia Raquel de Carvalho; Andrey Teixeira

http://dx.doi.org/10.1590/S0034-70942005000400007 Braz J Anesthesiol, vol.55, n4, p.429-440, 2005
PDF Português
PDF English
Downloads: 2
Views: 1414

Resumo

JUSTIFICATIVA E OBJETIVOS: A insuficiência renal aguda peri-operatória é responsável por elevada taxa de morbidade e mortalidade. Os fármacos alfa2-agonistas aumentam o débito urinário e promovem boa estabilidade hemodinâmica nesse período. O objetivo desta pesquisa foi estudar os efeitos renais e sobre a concentração plasmática do hormônio antidiurético (HAD) provocados pela dexmedetomidina no cão anestesiado. MÉTODO: Trinta e seis cães adultos, anestesiados com propofol, fentanil e isoflurano, foram divididos aleatoriamente em três grupos que receberam, de modo encoberto: G1 - injeção de 20 mL de solução de cloreto de sódio a 0,9%, em 10 minutos, seguida de injeção de 20 mL da mesma solução em uma hora; G2 - injeção de 20 mL de solução de cloreto de sódio a 0,9% contendo dexmedetomidina (1 µg.kg-1), em 10 minutos, seguida de injeção de 20 mL da mesma solução, com a mesma dose de dexmedetomidina (1 µg.kg-1), em uma hora e G3 - injeção de 20 mL de solução de cloreto de sódio a 0,9% contendo dexmedetomidina (2 µg.kg-1) em 10 minutos, seguida de injeção de 20 mL da mesma solução, com a mesma dose de dexmedetomidina (2 µg.kg-1), em uma hora. As variáveis renais, hemodinâmicas e a concentração plasmática do HAD foram estudadas em quatro momentos: M1 (controle) - imediatamente após o período de estabilização; M2 - após a injeção inicial de 20 mL da solução em estudo, em 10 minutos, coincidindo com o início da injeção da mesma solução, em uma hora; M3 - 30 minutos após M2 e M4 - 30 minutos após M3. RESULTADOS: A dexmedetomidina reduziu a freqüência cardíaca e promoveu estabilidade hemodinâmica, mantendo constante o débito cardíaco. Houve elevação do débito urinário no G2 e G3, em comparação com o G1. A osmolalidade urinária no G2 e G3 foi menor no M3 e M4 em relação ao M1 e M2. A depuração de água livre aumentou no G3. A concentração plasmática do HAD diminuiu no G3, apresentando valores mais baixos que os observados no G1 e G2 em M2 e M4. CONCLUSÕES: Os cães anestesiados com baixas doses de dexmedetomidina promovem diurese hídrica por inibir a secreção do hormônio antidiurético, havendo potencial para proteção renal em eventos isquêmicos.

Palavras-chave

ANIMAIS, DROGAS, DROGAS, SISTEMA RENAL

Abstract

BACKGROUND AND OBJECTIVES: Perioperative acute renal failure increases morbidity and mortality. Alpha2-adrenergic agonists used in anesthesia increase urinary output and maintain cardiovascular stability. This study aimed at investigating the effects of dexmedetomidine on renal system and on vasopressin plasma levels in anesthetized dogs. METHODS: This study involved 36 adult mixed-breed dogs anesthetized with propofol, fentanyl, and isoflurane, which were randomly distributed in three groups receiving: G1 -20 mL of 0.9% saline in 10 minutes, followed by 20 mL of the same solution in one hour; G2 -20 mL of 0.9% saline with dexmedetomidine (1 µg.kg-1) in 10 minutes, followed by 20 mL of the same solution with the same dexmedetomidine dose (1 µg.kg-1) in one hour; and G3 -20 mL of 0.9% saline with dexmedetomidine (2 µg.kg-1) in 10 minutes, followed by 20 mL of the same solution with the same dexmedetomidine dose (2 µg.kg-1) in one hour. Renal and hemodynamic variables and vasopressin plasma levels were studied in four periods: M1 (control) - immediately after the stabilization period; M2 - after initial injection of the solution being studied, coinciding with the beginning of continuous injection of the same solution; M3 - 30 minutes after M2; and M4 - 30 minutes after M3. RESULTS: Dexmedetomidine has decreased heart rate and maintained adequate cardiovascular stability, as cardiac output was kept constant. Urinary output was increased for G2 and G3 as compared to G1. For G2 and G3, urinary osmolality has decreased in M3 and M4. For G3, values of free water clearance were increased throughout the experiment. Vasopressin plasma levels have decreased for G3, resulting in lower values as compared to G1 and G2 in M2 and M4. CONCLUSIONS: In anesthetized dogs, low doses of dexmedetomidine inhibit vasopressin secretion, causing aqueous diuresis. These actions might protect kidneys during ischemic events.

Keywords

ANIMALS, DRUGS, DRUGS, RENAL SYSTEM

References

Godet G, Fleron MH, Vicaut E. Risk factors for acute postoperative renal failure in thoracic or thoracoabdominal aortic surgery: a prospective study. Anesth Analg. 1997;85:1227-1232.

Mangano CM, Diamondstone LS, Ramsay JG. Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes and hospital resource utilization. Ann Intern Med. 1998;128:194-203.

Conlon PJ, Stafford-Smith M, White WD. Acute renal failure following cardiac surgery. Nephrol Dial Transplant. 1999;14:1158-1162.

Swaminathan M, Stafford-Smith M. Renal dysfunction after vascular surgery. Curr Opin Anaesthesiol. 2003;16:45-51.

Lema G, Canessa R, Urzua J. Renal preservation in cardiac surgery. Curr Opin Anesthesiol. 1998;11:9-13.

Scheinin M, Kallio A, Koulu M. Sedative and cardiovascular effects of medetomidine, a novel seletive alpha2-adrenoceptor agonist, in healthy volunteers. Br J Clin Pharmacol. 1987;24:443-451.

Kallio A, Scheinin M, Koulu M. Effects of dexmedetomidine, a seletive alpha2-adrenoceptor agonist, on hemodynamic control mechanisms. Clin Pharmacol Ther. 1989;46:33-42.

Aho M, Scheinin M, Lehtinen AM. Intramusculary administered dexmedetomidine attenuates hemodynamic and stress hormone responses to gynecologic laparoscopy. Anesth Analg. 1992;75:932-939.

Talke P, Chen R, Thomas B. The hemodynamic and adrenergic effects of perioperative dexmedetomidine infusion after vascular surgery. Anesth Analg. 2000;90:834-839.

Jalonen J, Hynynen M, Kuitunen A. Dexmedetomidine as an anesthetic adjunct in coronary artery bypass grafting. Anesthesiology. 1997;86:331-345.

Aires MM. Fisiologia Renal. Fisiologia. 1999:473-488.

Maze M, Tranquilli W. Alpha-2 adrenoceptor agonists: defining the role in clinical anesthesia. Anesthesiology. 1991;74:581-605.

Hamaya Y, Nishikawa T, Dohi S. Diuretic effect of clonidine during isoflurane, nitrous oxide, and oxygen anesthesia. Anesthesiology. 1994;81:811-819.

Evans RG, Shweta A, Malpas SC. Renal effects of rilmenidine in volume-loaded anaesthetized dogs. Clin Exp Pharmacol Physiol. 1997;24:64-67.

Cabral AD, Kapusta DR, Kenigs VA. Central alpha2-receptor mechanisms contribute to enhanced renal responses during ketamine-xylazine anesthesia. Am J Physiol. 1998;275:R1867-R1874.

Brooks DP, Edwards RM, Depalma PD. The water diuretic effect of the alpha-2 adrenoceptor agonist, AGN 190851, is species-dependent. J Pharmacol Exp Ther. 1991;259:1277-1282.

Reid IA, Nolan PL, Wolf JA. Suppression of vasopressin secretion by clonidine: effect of alpha-adrenoceptor antagonists. Endocrinology. 1979;104:1403-1406.

Rouch AJ, Kudo LH, Hebert C. Dexmedetomidine inhibits osmotic water permeability in the rat cortical collecting duct. J Pharmacol Exp Ther. 1997;281:62-69.

Schmitz JM, Graham RM, Sagalowsky A. Renal alpha-1 and alpha-2 adrenergic receptors: biochemical and pharmacological correlations. J Pharmacol Exp Ther. 1981;219:400-406.

Michel MC, Brodde OE, Schnepel B. [3H]-idazoxan and some other alpha2-adrenergic drugs also bind with affinity to a nonadrenergic site. Mol Pharmacol. 1989;35:324-330.

Calianos T 2nd, Muntz KH. Autoradiographic quantification of adrenergic receptors in rat kidney. Kidney Int. 1990;38:39-46.

Stanko CK, Vandel MI, Bose R. Characterization of alpha2-adrenoceptors in the rat: proximal tubule, renal membrane and whole kidney studies. Eur J Pharmacol. 1990;175:13-20.

Clarke D, Garg LC. Alpha-2 adrenergic receptors in inner medullary collecting duct cells of the rabbit kidney. J Pharmacol Exp Ther. 1993;264:879-888.

Mohuczy-Dominiak D, Garg LC. Alpha-2 adrenoceptors in medullary thick ascending limbs of the rabbit kidney. J Pharmacol Exp Ther. 1993;266:279-287.

Evans RG, Haynes JM. Characterization of binding sites for [3H]-idazoxan, [3H]-P-aminoclonidine and [3H]-rauwolscine in the kidney of the dog. Clin Exp Pharmacol Physiol. 1994;21:649-658.

Chabardes D, Montegut M, Imbert-Teboul M. Inhibition of alpha2-adrenergic agonists on AVP-induced cAMP accumulation in isolated collecting tubules of the rat kidney. Mol Cell Endocrinol. 1984;37:263-275.

Umemura S, Marver D, Smyth DD. Alpha2-adrenoceptors and cellular cAMP levels in single nephron segments from the rat. Am J Physiol. 1985;249:F28-F33.

Humphreys MH, Reid IA. Suppression of antidiuretic hormone secretion by clonidine in the anesthetized dog. Kidney Int. 1975;7:405-412.

Barr JG, Kauker ML. Renal tubular site and mechanism of clonidine-induced diuresis in rats: clearance and micropuncture studies. J Pharmacol Exp Ther. 1979;209:389-395.

Barker JL, Crayton JW, Nicoll RA. Noradrenaline and acetylcholine responses of supraoptic neurosecretory cells. J Physiol. 1971;218:19-32.

Kimura T, Share L, Wang BC. The role of central adrenoreceptors in the control of vasopressin release and blood pressure. Endocrinology. 1981;108:1829-1836.

Cowley AW Jr. Vasopressin and cardiovascular regulation. Int Rev Physiol. 1982;26:189-242.

Leander JD, Zerbe RL, Hart JC. Diuresis and supresion of vasopressin by kappa opioids: comparison with mu and delta opioids and clonidine. J Pharmacol Exp Ther. 1985;234:463-469.

Reid IA, Ahn JN, Trinh T. Mechanism of suppression of vasopressin and adrenocorticotropic hormone secretion by clonidine in anesthetized dogs. J Pharmacol Exp Ther. 1984;229:1-8.

Villela NR, Nascimento Jr P. Uso de dexmedetomidina em Anestesiologia. Rev Bras Anestesiol. 2003;53:97-113.

Solez K, Ideura T, Silvia CB. Clonidine after renal ischemia to lessen acute renal failure and microvascular damage. Kidney Int. 1980;18:309-322.

Kulka P, Tryba M, Zenz M. Preoperative alpha2-adrenergic receptor agonists prevent the deterioration of renal function after cardiac surgery: results of a randomized, controlled trial. Crit Care Med. 1996;24:947-952.

5dd6ea280e8825a45313f286 rba Articles
Links & Downloads
2352-2291 (Electronic) 0104-0014 (Printed)
Braz J Anesthesiol ©2024 All rights reserved.

Braz J Anesthesiol

Share this page
Page Sections